Research of the Correlations Between Serum Levels of VEGFR-2, Endostatin and Clinical Characters in Patients with Non-Small Cell Lung Cancer

YANG Yi,ZHAO Tiancheng,GAO Zongli,WANG Xiuzhen

DOI: https://doi.org/10.3969/j.issn.1673-7210.2011.33.009

2011-01-01

Abstract:Objective: To study the relationship between clinical significance and the serum levels of vascular endothelial growth factor receptor 2(VEGFR-2),endostatin(ES) in patients with non-small cell lung cancer(NSCLC).Methods: The serum VEGFR-2,ES levels were detected by ELISA method in 38 patients with NSCLC in Shanghai 6th People's Hospital cardiothoracic surgery department in 2009.The correlations were analyzed among VEGFR-2,ES and the clinical characters,age,sex,pathology,diameter of tumor,clinical stage,micro vessel density(MVD) of tumor.Results: The serum level of ES [(20.29±6.10) μg/L] was uncorrelated with that of VEGFR-2 [(7.42±4.28) μg/L](P0.05);the serum level of ES was correlated with MVD of tumor(r=-0.867,r2=0.752),the linear regression equation was [Y=32.002-0.499X(μg/L)](P0.001);ES and VEGFR2 were uncorrelated with the other clinical characters.Conclusion: The serum level of ES may change the MVD of tumor,ES,VEGFR-2 and the clinical characters are uncorrelated in NSCLC patients.It suggests that VEGFR-2 and ES may be failed to be used as effective markers to predict stages and prognosis in NSCLC patients.